This is a working overview of Peptide stability, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-04-17. Anything still debated is marked as such rather than presented as settled.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
Thymosin alpha-1 is supplied as a lyophilized powder in most research settings. The solid dissolves readily in water and in common aqueous buffers, and it is typically reconstituted shortly before use. Solutions are clear and colourless at ordinary working concentrations. Because the peptide is hygroscopic, weighing and reconstitution are usually performed with minimal exposure to ambient air. Aliquots are prepared to avoid repeated freeze-thaw cycles, and working solutions are kept cold.
Long-term storage is generally at minus twenty degrees Celsius or colder, preferably desiccated and protected from light. Lyophilized material is more stable than reconstituted solution, which degrades faster at room temperature. Stability depends on pH, ionic strength, and the presence of oxidising agents. Published stability data for the peptide are limited, so storage claims in catalogues should be treated as general guidance rather than measured guarantees. Freeze-thaw cycles are kept to a minimum.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Acetylated peptide | N-terminal acetyl group blocks aminopeptidase attack |
| Residue count | 28 amino acids | Matches the N-terminus of prothymosin alpha |
| Molecular mass | About 3,108 Da | Value for the free, unmodified peptide |
| Isoelectric point | Approximately 4.2 | Acidic; net negative charge at neutral pH |
| Encoding gene | PTMA | Human gene for the precursor protein |
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Routine handling calls for storage of the lyophilized powder at refrigerated temperatures, away from light, in a sealed container. Working solutions are often prepared in sterile water or buffer and kept cold between uses. Repeated freeze-thaw cycles are generally avoided because they can promote aggregation and loss of material. Laboratories usually record lot number, reconstitution date, and storage conditions so that any change in behavior can be traced to a specific preparation.
Reverse-phase high-performance liquid chromatography is the standard technique for assessing purity and concentration, because the peptide's hydrophobicity allows clean separation from related impurities. Mass spectrometry confirms molecular identity and detects sequence errors or truncations. Amino acid analysis and peptide mapping supply additional structural confirmation when required. Chromatographic purity values reported on certificates of analysis describe the proportion of the main peak and do not by themselves establish biological activity.
Conversely, the catabolic effect was much less in an older male, and no such effect was observed in adult females consuming a diet with sufficient calories and protein. The catabolic effects of CPA were found to be greater than those of corticosteroids. Although higher doses of CPA are necessary for considerable systemic AR antagonistic activity, it is notable that even low doses of oral CPA appear to be able to significantly antagonize AR signaling in the liver in women. This may be related to the hepatic first-pass effect of oral administration, and is evidenced by the fact that whereas combined birth control pills containing CPA increase SHBG levels by 300 to 400%, combined birth control pills containing various other progestins, with either androgenic or antiandrogenic activity, increase SHBG levels by only 50 to 300%. This is relevant as estrogens stimulate hepatic SHBG production while androgens inhibit hepatic SHBG production, and vice versa for their antagonists. The antiandrogenic activity of CPA may also be responsible for the relatively greater risk of venous thromboembolism with CPA-containing birth control pills compared to those containing other progestins. In rats, a dosage of CPA of 25 mg/kg/day results in complete regression of prostate gland growth in gonadally intact males. The equivalent dosage in humans, on the basis of body surface (conversion factor from rat to human of 6), was estimated to be approximately 4 mg/kg/day, or around 300 mg/day CPA for a 75 kg (165 lb) man.
=== August === 1 August Tony Brien, 54, footballer (Leicester City, Chesterfield, Rotherham United, West Bromwich Albion, Mansfield Town, Chester City, Hull City). John Madigan, 76, hurler (Charleville, Avondhu) and rugby union player (UL Bohemians, Munster). 4 August – Colin O'Daly, 70, chef. 9 August – Art McRory, 82, Gaelic footballer (Dungannon, Tyrone senior team) and manager (Tyrone minor and senior teams). Born in Northern Ireland. 15 August – Liam McDaid, 78, Roman Catholic prelate. 23 August – Chryss Goulandris, 73, businesswoman, horse breeder and wife of Tony O'Reilly. Born in the United States.
Dualism A philosophical position asserting that the mind and body are fundamentally distinct entities. In neuroscience, it contrasts with monistic and physicalist views of consciousness. Dynein A motor protein that moves along microtubules in the cytoskeleton, transporting cellular cargo toward the center of the cell. In neurons, dynein is important for retrograde axonal transport. Dysarthria A motor speech disorder resulting from impaired control of the muscles used in speech, often due to neurological damage to the brainstem or cerebellum. Dyskinesia Involuntary, erratic, or repetitive movements, often associated with long-term use of dopaminergic drugs in Parkinson’s disease. Dyslexia A neurodevelopmental disorder characterized by difficulty with accurate and/or fluent word recognition, often linked to deficits in phonological processing and left hemisphere brain function. Dyspraxia A developmental coordination disorder involving difficulty with motor planning and execution, affecting balance, fine motor tasks, and speech.
Sources: en.wikipedia.org
Gunboat diplomacy March–May 2025 United States attacks in Yemen Operation Inherent Resolve US intervention in Somalia (2007–present) Ecuadorian conflict (2024–present) Shield of the Americas Joint Interagency Task Force-Counter Cartel
== Isotopic abundance == The monoisotopic peak is sometimes not observable for two primary reasons. First, the monoisotopic peak may not be resolved from the other isotopic peaks. In this case, only the average molecular mass may be observed. In some cases, even when the isotopic peaks are resolved, such as with a high-resolution mass spectrometer, the monoisotopic peak may be below the noise level and higher isotopes may dominate completely. If a piece of iron was put into a mass spectrometer to be analyzed, the mass spectra of iron (Fe) would result in multiple mass spectral peaks due to the existence of the iron isotopes, 54Fe, 56Fe, 57Fe, 58Fe. The mass spectrum of Fe represents that the monoisotopic mass is not always the most abundant isotopic peak in a spectrum despite it containing the most abundant isotope for each atom. This is because as the number of atoms in a molecule increases, the probability that the molecule contains at least one heavy isotope atom also increases. If there are 100 carbon atoms 12C in a molecule, and each carbon has a probability of approximately 1% of being a heavy isotope 13C, the whole molecule is highly likely to contain at least one heavy isotope atom of carbon-13 and the most abundant isotopic composition will no longer be the same as the monoisotopic peak.
=== Scalp hair loss === Clascoterone is under development for the treatment of androgen-dependent scalp hair loss. Two phase 3 clinical trials were completed and disclosed in December 2025. The drug significantly improved hair growth in both trials. More specifically, target area hair count (TAHC) had a relative improvement of 5.39-fold (539%) in one study and of 1.68-fold (168%) in the other study, both compared to placebo. In other words, hair growth improved in both the placebo and clascoterone groups, but growth improved by about 1.7- to 5.4-fold more with clascoterone than with placebo. The actual absolute changes in hair counts in the different groups have not yet been released.
Sources: en.wikipedia.org
Thymosin fraction 5 is a mixture of many peptides obtained from thymus tissue, while thymosin alpha 1 is a single defined 28-residue molecule. The two names appear together in older literature because the purified peptide was first obtained from that mixture.
The precursor, prothymosin alpha, is encoded by the PTMA gene in humans. The 28-residue peptide corresponds to the N-terminal segment released from that larger protein.
It is produced as a fragment of prothymosin alpha and is present in many tissues. Circulating concentrations are low, which makes routine measurement difficult.
Lyophilized powder is normally kept at minus twenty degrees Celsius or below, in a sealed container, desiccated and away from light. Reconstituted solutions are less stable and are usually refrigerated and used quickly. Repeated temperature cycling should be avoided.